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OBJECTIVE: Successful revascularization of chronic total occlusions has been associated with improved left
ventricular systolic function, reduced anginal symptoms, increased exercise capacity, and increased survival. This
study was conducted to determine the impact of revascularization in chronic total occlusion on left ventricular
function using novel echocardiographic techniques.
METHODS: A total of 129 patients with chronic total occlusion who underwent revascularization between April
2011 and November 2012 were included in this study. Echocardiographic assessments with two-dimensional
speckle tracking echocardiography and real-time three-dimensional echocardiography were performed before
the procedure and one month after the procedure. The left ventricular ejection fraction, left ventricular
volumes, and three-dimensional systolic dyssynchrony index were quantified.
RESULTS: An immediate procedural success was obtained in 118 patients (91.5%). There were no acute or
subacute stent thromboses during follow-up. The mean left ventricular ejection fraction significantly increased
(p,0.001), while the left ventricular end-diastolic and end-systolic volumes significantly decreased (p=0.001
and p,0.001, respectively). The three-dimensional systolic dyssynchrony index also decreased significantly
(p,0.001). The global longitudinal strain showed a significant increase after successful revascularization
(p,0.001). An increase in the global longitudinal strain was correlated with an increase in the left ventricular
ejection fraction (r = 0.27, p=0.02). The patients with a left ventricular ejection fraction $50% displayed a
greater improvement in the global longitudinal strain, and the patients with diabetes showed less
improvement.
CONCLUSIONS: Using novel echocardiographic techniques, our results showed that restoring the coronary
blood flow in chronic total occlusion patients reduces the left ventricular volumes and improves the left
ventricular ejection fraction and the global longitudinal strain of hibernating myocardium.
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& INTRODUCTION
Coronary artery chronic total occlusion (CTO) is one of
the most challenging obstacles faced by interventional
cardiologists. Approximately one-third to one-half of the
patients with significant coronary artery disease (CAD) on
angiography have at least one CTO (1,2). Although
collaterals are capable of maintaining myocardial viability
at rest, they may fail to provide adequate blood flow during
exercise, which can result in angina. Successful percuta-
neous coronary interventions (PCIs) of CTOs have been
shown to improve the left ventricular (LV) systolic function,
reduce angina, increase exercise capacity, and reduce the
need for late bypass surgery (3-5).
An accurate assessment of LV function by determining
the LV volumes and the ejection fraction (EF) is important in
evaluating the prognoses of patients with CAD. Two-
dimensional speckle tracking echocardiography (2D-STE)
can assess the global LV function, and it is superior for EF
measurements because it is angle-independent, less subject
to artifacts, and easier to conduct than Doppler-derived
tissue velocity imaging (6,7). Based on 2D-STE, automated
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function imaging is used to reflect the systolic LV function
by assessment of the LV global longitudinal strain (GLS).
Longitudinal tissue deformation is evaluated by frame-
by-frame tracking of the individual speckles throughout
the cardiac cycle. This imaging technique discriminates
between active and passive myocardial motion and enables
angle-independent quantification of myocardial deforma-
tion in two dimensions (8,9). 2D-STE is based on tracking
the characteristic speckle patterns created by interference of
ultrasound beams in the myocardium, and its accuracy has
been confirmed using sonomicrometry and magnetic
resonance imaging (MRI) as reference methods (10).
The aim of this study was to investigate the changes in the
LV volumes, LVEF, and GLS of patients with CTO, before
and one month after PCI, using novel echocardiographic
methods.
& MATERIALS AND METHODS
Patient selection
A total of 129 patients with CTO who had attempted PCI
at Bezmialem Foundation University Hospital between
April 2011 and November 2012 were screened for inclusion
in this study. Eleven patients who had failed PCI were
excluded, and 118 patients who had been successfully
revascularized were included in the study. All of the
patients underwent physical examination, chest X-ray, 12-
lead electrocardiography (ECG), and transthoracic echocar-
diographic (2DE) evaluations. Echocardiography was also
repeated one month after the revascularization procedure.
CTO was defined as lumen compromise resulting in either
Thrombolysis In Myocardial Infarction (TIMI) flow grade 0
or 1, with a likely duration of .3 months (11). All of the
patients included had a native vessel occlusion estimated to
be of at least three months in duration based on a history of
sudden chest pain, a previous myocardial infarction (MI) in
the same target vessel territory, or the time between
diagnosis made on coronary angiography and PCI. All of
the patients had symptomatic angina and/or a positive
functional ischemia study. PCI and stent implantation were
performed in a standard manner. Drug-eluting stents
(DESs) were used in all of the angioplasty procedures.
Heparin was administered to maintain an activated clotting
time .250 seconds. A PCI of the CTO was performed with
modern techniques such as bilateral injections; specialized
hydrophilic, tapered tip, and stiff wires; parallel wires;
microcatheters; and a retrograde approach when possible.
After the PCI, all of the patients were prescribed lifelong
aspirin. Clopidogrel was prescribed for at least 12 months in
all of the patients. The patients were followed prospectively
by a telephone interview or an outpatient visit after 30 days.
Procedural success was defined as the successful recanali-
zation and dilation of at least one CTO per patient with or
without stent implantation, a residual stenosis of,50%, and
a TIMI flow.2. The procedure time was defined as the time
difference between the patient’s entry and exit from the
catheterization room.
The study protocol was approved by the institutional
clinical research and ethics committee of Bezmialem
Foundation University Hospital, and all of the patients
provided written informed consent.
2DE and 2D-STE were performed on the subjects at rest in
the left lateral decubitus position with synchronized
electrocardiography by two professional cardiologists,
who were blinded to the clinical data, with a commercially
available system (Philips iE33, Bothell, WA, USA) equipped
with a broadband S5-1 transducer (frequency transmitted:
1.7 MHz; received: 3.4 MHz). The parasternal long-axis
views were used to derive the M-Mode measurements of
the left atrial (LA) size and the LV end-diastolic (LVEDD)
and end-systolic (LVESD) dimensions. The endocardial
borders were traced in the end-systolic frame of the 2D
images from the three apical views. Four consecutive end-
expiratory cardiac cycles using high-frame-rate (50 Hz or
more) harmonic imaging in each echocardiographic view
were acquired. The speckles were tracked frame by-frame
throughout the LV wall during the cardiac cycle, and basal,
mid, and apical regions of interest were created. The
operator manually adjusted the segments that failed to be
tracked. All of the measurements were made blinded to the
other results and the clinical details.
Real-time three-dimensional echocardiography (RT3DE)
images were obtained from an apical window with the
patient in the same position as for 2D-STE. Full-volume
images were gathered over four cardiac cycles using a
matrix array transducer (64 transducer; Philips iE33,
Andover, MA). Measurements of the 3D-LV volumes and
the 3D-EF were performed off-line (QLAB workstation
using 3D-Advanced Quantification, Philips). The systolic
dyssynchrony index (SDI) was defined as the standard
deviation of the time to minimum systolic volume of the 16
LV segments, expressed as a percent of the RR duration. A
higher SDI indicated greater LV dyssynchrony.
Intra-observer variability was determined by the observer
repeating the measurement of the GLS in 20 randomly
selected patients ten days after the first measurement. Inter-
observer variability was determined by another observer
measuring these variables in the same database. The intra-
and inter- observer reproducibility of GLS parameter was
shown acceptable. The intra- and inter- observer variations
were 5.4% and 6.7% for GLS, respectively.
Statistical analysis
The continuous variables are reported as the mean ¡
standard deviations (SD), and the categorical variables are
expressed as percentages. Comparisons of the categorical
and continuous variables between the two groups were
performed using the x2 test and an unpaired t-test,
respectively. The GLS and velocities were compared using
an independent two sample t-test. The correlation between
the GLS and LVEF variables was tested using a correlation
analysis. The delta values are defined as the difference
between the first month and the preprocedure value. A
value of p,0.05 was considered statistically significant. The
SPSS 15.0 for Windows statistical software package program
(SPSS Inc., Chicago, IL, USA) was used for the statistical
analysis.
& RESULTS
Table 1 shows the baseline demographic, angiographic,
and procedural characteristics of the study patients. The
mean age of the patients was 58¡9 years. There were no
acute or subacute stent thrombosis. Therewas no death, acute
MI, coronary perforation, emergency re-PCI, emergency
coronary artery bypass graft surgery (CABG), or acute stroke
during the periprocedural period. Pericardiocentesis was
required for only one patient because of tamponade. The
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mean procedure time was 79¡39 min, the fluoroscopy time
was 34¡19 min, and the amount of contrast was 492¡174 ml.
Contrast-induced nephropathy was developed in 14 (11%)
patients, and one patient underwent hemodialysis.
Half of the patients (63 patients, 48.8%) suffered from
angina pectoris ($2 CCS) before the procedure, and the
occurrence of angina pectoris decreased significantly after
PCI. Compared with the measurements before the proce-
dure, the LVEDV and LVESV decreased significantly
(p= 0.001 and p,0.001, respectively) and the mean LVEF
increased significantly (p,0.001) after the procedure. The
SDI derived from RT3DE decreased significantly after
successful revascularization (p,0.001). The GLS increased
significantly one month after PCI (p,0.001) (Table 2). We
found that the increase in the GLS was correlated with an
improvement in the LVEF (r= 0.27, p= 0.02; Figure 1). The
patients with an LVEF $50% displayed greater improve-
ment in the GLS compared with the patients with an LVEF
,50% (1.1¡0.9 vs. 0.12¡0.3, p,0.001). The patients with
diabetes mellitus (DM) showed a lower degree of GLS
improvement compared with the patients without DM
(1.1¡1.0 vs. 0.62¡0.6, p= 0.07).
& DISCUSSION
In this study, we used 2DSTE and RT3DE to determine
that successful revascularization of CTO of the coronary
arteries may improve the LV contractile function. We found
that the improvement in the myocardial contractile function
based on strain analysis seems to be more significant in the
patients with a LVEF $50% and less significant in the
patients with DM. To the best of our knowledge, this is the
first study showing the benefit of revascularization of CTOs
on LV function using 2DSTE and RT3DE.
LV systolic function is most commonly assessed by the
LVEF using 2DE. The assessment of patients with CTO may
be challenging with 2DE because many of these patients
suffer from long-term myocardial ischemia or MI and
develop aneurysmal formation or advanced ventricular
remodeling. Strain and strain rate imaging using the 2D-
STE method is a novel echocardiographic technique for the
evaluation of regional and global myocardial function, is
relatively free from angle dependency and the frame-rate
limitations of tissue Doppler imaging, and enables calcula-
tions to be made more easily. The global LV contractile
function, as assessed by 2D-STE, was shown to be superior to
EF measurements by 2DE (6,7). RT3DE is the other new
echocardiographic technique for calculating the actual LV
volume based on the actual LV shape, rather than on
geometrical assumptions. It has good reproducibility even
in cases of heart cavity deformation or segmental wall motion
abnormalities. It is more accurate than 2DE, and its accuracy
approaches that of the gold standard, namely MRI (12,13).
Despite the presence of coronary collaterals, the majority
of patients with a CTO show various degrees of LV
dysfunction. The possibility of a functional recovery and
its beneficial effect on survival are the rationale for the often
technically demanding attempt to recanalize a CTO (3-5,14-
18). Recovery of LV function in chronically ischemic
myocardium depends on the presence of hibernating or
stunned but viable myocardium (19). When reperfusion is
acquired, the hibernating myocardium at least partially
restores the contractile function, resulting in regional and
global LV function recovery (20). Baks et al. showed the
beneficial effect of successful CTO revascularization on the
end-systolic and end-diastolic volumes. They showed that
the extent of dysfunctional but viable myocardium before
revascularization was related to an improvement in the end-
systolic volume and LVEF (21). In the present study, we
found a reduction in LV volumes; however, we used
RT3DE, which is more robust than 2DE. Cheng et al. used
contrast-enhanced MRI to demonstrate that successful CTO-
PCI results in improved LV function and attenuated LV
remodeling if the vessel patency is maintained (22). The
improvements in LVEF and myocardial function in our
study, based on 2DSTE and RT3DE, are consistent with the
results of Cheng et al. The improvements in the LVEF and
GLS observed in the current study may be a result of the
recovered hibernating myocardium.
Multiple retrospective studies have shown the potential
benefit of PCI in patients with CTO. Successful treatment
improves anginal symptoms, exercise tolerance, and LV
function. The prospective Total Occlusion Angioplasty
Study (TOAST-GISE) showed that revascularization of a
CTO is associated with relieved angina and reduces the 12-
month incidence of cardiac death or MI and the need for
CABG (5). Joyal et al. recently identified 13 observational
studies comparing the outcomes after successful versus
failed CTO recanalizations, showing that successful CTO
recanalization was associated with a 44% reduction in
mortality, a 78% reduction in the subsequent need for
CABG, and a 55% reduction in residual or recurrent angina
Table 1 - The demographic, angiographic, and procedural
characteristics of the patients.
Patients (n = 129)
Age (years) 58¡9
Gender (men) (n, %) 106 (82)
Hypertension (n, %) 110 (85)
Diabetes mellitus (n, %) 47 (37)
Hyperlipidemia (n, %) 114 (88)
Smoking (n, %) 39 (30)
$2 CCS angina (n, %) 63 (49)
Left anterior descending artery (n, %) 35 (27)
Left circumflex artery (n, %) 22 (17)
Right coronary artery (n, %) 72 (56)
Procedure time (min) 79¡39
Fluoroscopic time (min) 34¡19
Amount of contrast media (ml) 492¡174
Contrast nephropathy (n, %) 14 (11)
CCS: Canadian Cardiovascular Society.
Table 2 - Echocardiographic measures of the successfully
revascularized patients before and one month after the
procedure (n= 118).
Preprocedure One month p-value
LVEDD (mm) 52.6¡4.9 52.3¡5.2 0.03
LVESD (mm) 33.5¡5.8 33.4¡5.9 0.3
3D end-diastolic volume (ml) 76.22¡22.55 71.98¡22.64 0.001
3D end-systolic volume (ml) 34.54¡16.49 31.63¡16.22 ,0.001
Mean 3D-LVEF (%) 56.31¡9.81 58.32¡10.2 ,0.001
3D-SDI (%) 4.2¡3.1 3.4¡2.3 ,0.001
Global longitudinal strain
(%)
-12.51¡1.81 -13.23¡2.29 ,0.001
3D-LVEF: three-dimensional left ventricular ejection fraction, LVEDD: left
ventricle end-diastolic diameter, LVESD: left ventricle end-systolic
diameter, SDI: systolic dyssynchrony index.
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(23). In accordance with the above mentioned studies,
successful revascularization of CTOs in our study resulted
in a significant improvement in anginal symptoms.
Approximately half of the patients did suffer from angina
CCS 2 or greater before the procedure, and none of them
had CCS 2 or greater after the procedure.
Numerous experimental studies have demonstrated that
ischemia depresses the regional systolic function, resulting
in severe systolic dyssynchrony, prolonged tension devel-
opment in the ischemic regions, and impaired global
relaxation (24,25). Bonow et al. reported that CAD was
associated with dyssynchrony, which improved after
mechanical revascularization (26). In the present study, the
SDI derived by RT3DE, which is a marker of dyssynchrony,
was improved one month after CTO revascularization. The
improvement in dyssynchrony may be related to an
improvement in the hibernating myocardium and in
decreased LV volumes.
Endothelial dysfunction, structural changes of the micro-
circulation, and a negative influence on the development
and prognosis of CAD are well-established features of
patients with DM (27-29). Patients with DM have a greater
extent of CAD and are prone to impaired clinical outcomes
compared with nondiabetic patients (30-32). A previous
observational study about CTO PCI in diabetics was
performed by Safley et al. They reported that DM patients
do not seem to have the same survival benefits from
successful PCI of a CTO as patients without DM (33). In our
study, we found relatively less improvement in the GLS in
diabetic patients. It is still not clear why diabetics benefit
less from PCI of a CTO, but we speculate that the extensive
atherosclerosis and impaired microvascular circulation may
explain the worse outcomes in this population.
Limitations
There are several limitations to this study. The main
limitation is its observational nature and the fact that it was
nonrandomized. Additionally, the duration of occlusion
was not known with certainty in some of the cases. A lack of
follow-up data beyond the hospital stay is another limita-
tion.
Our results showed that restoring the blood flow to
dysfunctional but viable myocardium led to a moderate
improvement in LV function and a reduction in the adverse
remodeling in the majority of patients with a CTO.
Angiographical success was accompanied by anginal relief.
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